CareCloud (CCLD)
(Delayed Data from NSDQ)
$2.37 USD
+0.05 (1.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $2.36 -0.01 (-0.42%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.37 USD
+0.05 (1.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $2.36 -0.01 (-0.42%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
Zacks News
Omnicell (OMCL) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Omnicell (OMCL) delivered earnings and revenue surprises of 137.50% and 4.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Schrodinger (SDGR) delivered earnings and revenue surprises of 0% and 11.24%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CareCloud (CCLD) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
CareCloud (CCLD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of -110% and 1.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CareCloud, Inc. (CCLD) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
CareCloud, Inc. (CCLD) delivered earnings and revenue surprises of -32.14% and 8.34%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Schrodinger, Inc. (SDGR) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of 51.16% and 0.25%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CareCloud, Inc. (CCLD) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
CareCloud, Inc. (CCLD) delivered earnings and revenue surprises of 9.68% and 3.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 2.33% and 6.20%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
CareCloud, Inc. (CCLD) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
CareCloud, Inc. (CCLD) delivered earnings and revenue surprises of -10% and 3.92%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Invitae (NVTA) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Invitae (NVTA) delivered earnings and revenue surprises of 38.18% and 1.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health, Inc. (HIMS) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 28.57% and 4.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Talkspace, Inc. (TALK) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Talkspace, Inc. (TALK) delivered earnings and revenue surprises of 27.27% and 4.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?